Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson’s disease

Parkinson’s disease (PD) is the second most common neurodegenerative disease characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta and the presence of Lewy bodies, which gives rise to motor and non-motor symptoms. Unfortunately, current therapeutic strat...

Descripción completa

Detalles Bibliográficos
Autores principales: Fričová, Dominika, Korchak, Jennifer A., Zubair, Abba C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641157/
https://www.ncbi.nlm.nih.gov/pubmed/33298940
http://dx.doi.org/10.1038/s41536-020-00106-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641157/
https://www.ncbi.nlm.nih.gov/pubmed/33298940
http://dx.doi.org/10.1038/s41536-020-00106-y

Ejemplares similares